114 related articles for article (PubMed ID: 32748205)
21. E-Cigarette Flavoring Chemicals Induce Cytotoxicity in HepG2 Cells.
Rickard BP; Ho H; Tiley JB; Jaspers I; Brouwer KLR
ACS Omega; 2021 Mar; 6(10):6708-6713. PubMed ID: 33748584
[TBL] [Abstract][Full Text] [Related]
22. Are Electronic Cigarette Users at Increased Risk for Cardiovascular Disease?
Bhatnagar A
JAMA Cardiol; 2017 Mar; 2(3):237-238. PubMed ID: 28146233
[No Abstract] [Full Text] [Related]
23. Harmful effects of electronic cigarette on oral soft tissues mediated by dysbiosis: State of the art.
Ferrazzo KL; Ortigara GB; Bonzanini LIL
Oral Dis; 2024 May; 30(4):2719-2721. PubMed ID: 37660360
[No Abstract] [Full Text] [Related]
24. Oral nicotine pouches: a flavourful debate.
Wadhwa S
Br Dent J; 2024 May; 236(9):667-668. PubMed ID: 38730138
[No Abstract] [Full Text] [Related]
25. Brazilian Society of Cardiology Position Statement on the Use of Electronic Nicotine Delivery Systems - 2024.
Scholz JR; Malta DC; Fagundes Júnior AAP; Pavanello R; Bredt Júnior GL; Rocha MS
Arq Bras Cardiol; 2024 Feb; 121(2):e20240063. PubMed ID: 38422228
[No Abstract] [Full Text] [Related]
26. Public Health Concerns from Increased Use of Electronic Cigarette Use.
Koupidis SA
Angiology; 2024 May; 75(5):498-499. PubMed ID: 38149822
[No Abstract] [Full Text] [Related]
27. Early Cardiovascular Risk in E-cigarette Users: the Potential Role of Metals.
Navas-Acien A; Martinez-Morata I; Hilpert M; Rule A; Shimbo D; LoIacono NJ
Curr Environ Health Rep; 2020 Dec; 7(4):353-361. PubMed ID: 33242201
[TBL] [Abstract][Full Text] [Related]
28. Electronic Cigarette Vaping with Nicotine Causes Increased Thrombogenicity and Impaired Microvascular Function in Healthy Volunteers: A Randomised Clinical Trial.
Lyytinen G; Brynedal A; Anesäter E; Antoniewicz L; Blomberg A; Wallén H; Bosson JA; Hedman L; Mobarrez F; Tehrani S; Lundbäck M
Cardiovasc Toxicol; 2023 Aug; 23(7-8):255-264. PubMed ID: 37548804
[TBL] [Abstract][Full Text] [Related]
29. Biological Toxicity of the Compositions in Electronic-Cigarette on Cardiovascular System.
Lai L; Qiu H
J Cardiovasc Transl Res; 2021 Apr; 14(2):371-376. PubMed ID: 32748205
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use.
Benowitz NL; Burbank AD
Trends Cardiovasc Med; 2016 Aug; 26(6):515-23. PubMed ID: 27079891
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular risk of electronic cigarettes: a review of preclinical and clinical studies.
Buchanan ND; Grimmer JA; Tanwar V; Schwieterman N; Mohler PJ; Wold LE
Cardiovasc Res; 2020 Jan; 116(1):40-50. PubMed ID: 31696222
[TBL] [Abstract][Full Text] [Related]
32. Impact of Electronic Cigarettes on the Cardiovascular System.
Qasim H; Karim ZA; Rivera JO; Khasawneh FT; Alshbool FZ
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855171
[No Abstract] [Full Text] [Related]
33. Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: "What Are the Tools Needed for the Job?" and "Do We Have Them?".
Chandy M; Hill T; Jimenez-Tellez N; Wu JC; Sarles SE; Hensel E; Wang Q; Rahman I; Conklin DJ
Cardiovasc Toxicol; 2024 May; 24(5):435-471. PubMed ID: 38555547
[TBL] [Abstract][Full Text] [Related]
34. Immunological and toxicological risk assessment of e-cigarettes.
Kaur G; Pinkston R; Mclemore B; Dorsey WC; Batra S
Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29491036
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
